K
Kenneth M. Carpenter
Researcher at Columbia University
Publications - 63
Citations - 6847
Kenneth M. Carpenter is an academic researcher from Columbia University. The author has contributed to research in topics: Naltrexone & Cocaine dependence. The author has an hindex of 31, co-authored 62 publications receiving 5997 citations.
Papers
More filters
Journal ArticleDOI
Temperament characteristics, as assessed by the tridimensional personality questionnaire, moderate the response to sertraline in depressed opiate-dependent methadone patients.
Wilfrid N. Raby,Kenneth M. Carpenter,Efrat Aharonovich,Eric J. Rubin,Adam Bisaga,Frances R. Levin,Edward V. Nunes +6 more
TL;DR: The results suggest that temperament dimensions may be important for identifying substance dependent patients more likely to benefit from pharmacological interventions for comorbid depressive disorders.
Journal ArticleDOI
Building on shared experiences: The evaluation of a phone-based parent-to-parent support program for helping parents with their child's substance misuse
TL;DR: Remote parent-to-parent coaching appears promising for providing emotional and evidence-based informational support to family members parenting a child with substance use problems.
Journal ArticleDOI
Multimodal predictive modeling of individual treatment outcome in cocaine dependence with combined neuroimaging and behavioral predictors
TL;DR: It is suggested that a multimodal model can predict treatment success in cocaine dependence at an individual level, and pose hypotheses for the underlying neural circuitry mechanisms responsible for individual variations in treatment outcome.
Journal ArticleDOI
Quetiapine treatment for cannabis use disorder
John J. Mariani,Martina Pavlicova,C. Jean Choi,Cale Basaraba,Kenneth M. Carpenter,Amy L. Mahony,Daniel J. Brooks,Adam Bisaga,Nasir H. Naqvi,Edward V. Nunes,Frances R. Levin +10 more
TL;DR: The use of quetiapine to treat CUD was associated with an increased likelihood of heavy frequency use transitioning to moderate use, but not light use, and the clinical significance of reductions in cannabis use, short of abstinence warrants further study.
Journal ArticleDOI
Comparison of clinical trial recruitment populations: Treatment-seeking characteristics of opioid-, cocaine-, and cannabis-using participants
John J. Mariani,Wendy Y. Cheng,Adam Bisaga,Maria A. Sullivan,Kenneth M. Carpenter,Edward V. Nunes,Frances R. Levin +6 more
TL;DR: Cannabis-dependent individuals evaluated for clinical trial participation reported that recruitment advertising was an important factor in leading them to seek treatment, and public health efforts directed at encouraging cannabis- dependent individuals to seeking treatment have implications.